Arctigenin Protects against Lipopolysaccharide-Induced Pulmonary Oxidative Stress and Inflammation in a Mouse Model via Suppression of MAPK, HO-1, and iNOS Signaling

Galangin Dampens Mice Lipopolysaccharide-Induced Acute Lung Injury

(2014) Yu-Sheng Shu et al.   INFLAMMATION

Etanercept Attenuates Myocardial Ischemia/Reperfusion Injury by Decreasing Inflammation and Oxidative Stress

(2014) Mei Yang et al.   PLoS One

α-Dihydroxychalcone-glycoside (α-DHC) isolated from the heartwood of Pterocarpus marsupium inhibits LPS induced MAPK activation and up regulates HO-1 expression in murine RAW 264.7 macrophage

(2014) Prarthana Chakraborty et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation

(2013) Chia-Jung Hsieh et al.   FREE RADICAL BIOLOGY AND MEDICINE

Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury

(2013) Adriana Correa Melo et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B

(2013) Xian-ming Liang et al.   JOURNAL OF SURGICAL RESEARCH

Andrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB

(2013) Tao Zhu et al.   PLoS One

Arctigenin Protects Focal Cerebral Ischemia-Reperfusion Rats through Inhibiting Neuroinflammation

(2012) Tao Fan et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity

(2012) Xiangyang Yao et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Critical Role for CCAAT/Enhancer-Binding Protein   in Immune Complex-Induced Acute Lung Injury

(2012) C. Yan et al.   JOURNAL OF IMMUNOLOGY

Resolution of Experimental Lung Injury by Monocyte-Derived Inducible Nitric Oxide Synthase

(2012) F. R. D'Alessio et al.   JOURNAL OF IMMUNOLOGY

Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice

(2012) Guang-Zhen Bai et al.   JOURNAL OF SURGICAL RESEARCH

Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway

(2011) Xianjuan Kou et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models

(2011) Weimin Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Ethyl Pyruvate Reduces Acute Lung Injury Via Regulation of iNOS and HO-1 Expression in Endotoxemic Rats

(2011) Ching-Wen Kung et al.   JOURNAL OF SURGICAL RESEARCH

Long-Term Simvastatin Attenuates Lung Injury and Oxidative Stress in Murine Acute Lung Injury Models Induced by Oleic Acid and Endotoxin

(2011) N. D. Altintas et al.   Respiratory Care

Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6

(2011) Svitlana Danchuk et al.   Stem Cell Research & Therapy

Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I–IV allergic inflammation and pro-inflammatory enzymes

(2010) Ji Yun Lee et al.   ARCHIVES OF PHARMACAL RESEARCH

Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury

(2009) Katrin Schuh et al.   BIOCHEMICAL PHARMACOLOGY

Acute Lung Injury Review

(2009) Kenji Tsushima et al.   INTERNAL MEDICINE

Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan

(2008) V. Swarup et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY